P37.3 Congenital falciparum malaria

Name of the Condition

• Congenital falciparum malaria (ICD-10-CM Code: P37.3)

Summary

Congenital falciparum malaria is a rare condition where a newborn acquires Plasmodium falciparum infection in utero, typically from an infected mother. The infection can present with symptoms at birth or shortly after, and requires prompt recognition and treatment to prevent severe complications.

Causes

The infection is transmitted from the mother to the fetus via the placenta during pregnancy. Maternal malaria, particularly active P. falciparum infection, is the primary source of transmission. The parasite can cross the placental barrier, leading to fetal infection.

Risk Factors

• Maternal active P. falciparum malaria during pregnancy
• Lack of prenatal malaria screening or treatment in endemic regions
• Maternal exposure to high-transmission areas (e.g., tropical or subtropical regions)
• Inadequate maternal antimalarial prophylaxis or treatment

Symptoms

Symptoms may include fever, anemia, jaundice, hepatosplenomegaly, or neurologic signs (e.g., seizures, irritability). Some infants may present with subtle or delayed manifestations, requiring clinical vigilance.

Diagnosis

Diagnosis involves maternal history of malaria, newborn physical examination, and laboratory testing (e.g., blood smears, PCR, or antigen detection) to identify P. falciparum. Additional tests may assess anemia, jaundice, or organ involvement.

Treatment Options

Treatment typically involves antimalarial medications (e.g., artemisinin-based therapies) tailored to the infant’s age and severity. Supportive care, such as blood transfusions or management of complications, may be necessary.

Prognosis and Follow-Up

Prognosis depends on early diagnosis and treatment. With prompt intervention, outcomes can be favorable, but severe cases may lead to long-term complications. Follow-up includes monitoring for recurrence or delayed symptoms.

Complications

Potential complications include severe anemia, cerebral malaria, respiratory distress, or organ damage. Untreated or delayed treatment increases the risk of mortality or neurodevelopmental issues.

Lifestyle & Prevention

Prevention focuses on maternal malaria prevention during pregnancy, including prophylaxis in endemic areas and prompt treatment of maternal infections. Avoiding mosquito exposure and using insecticide-treated bed nets are key strategies.

When to Seek Professional Help

Seek immediate medical attention if a newborn shows signs of infection (e.g., fever, poor feeding, jaundice) or if the mother had malaria during pregnancy. Early evaluation is critical for timely diagnosis and treatment.

Tips for Medical Coders

Document the presence of congenital P. falciparum infection, including maternal history of malaria, timing of transmission, and clinical manifestations. Ensure coding aligns with confirmed laboratory or clinical evidence of the condition.